Cosmetic composition for calming skin, containing mountain ginseng root protoplast and 2, 3-butanediol
Through the combination of ginseng root protoplasts and 2,3-butanediol, the problem of insufficient research on ginseng protoplast cosmetics and unclear skin sedation effect was solved, and significant inflammatory factors were achieved Inhibition and relief of skin irritation provide an effective method of skin calming.
Patent Information
- Application Number
- CN202410176534.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-12-06
- Filing Date
- 2024-02-08
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, the research on ginseng protoplasts as cosmetic compositions is insufficient, and the effect of 2,3-butanediol in calming the skin is not clear, making it difficult to effectively alleviate skin inflammation caused by irritation.
The composition of ginseng root protoplast and 2,3-butanediol is used to achieve skin calming and irritating relief by reducing the expression of inflammatory factors caused by stimulation, including the use of the composition in cosmetics or pharmaceutical external products. To inhibit the expression of IL-6, IL-8 and NO.
Significantly reduces the expression of inflammatory factors induced by UV and LPS, effectively calms the skin and relieves skin irritation, demonstrating the synergistic effect of ginseng root protoplasts with 2,3-butanediol, providing an excellent skin calming and irritation Remission method.
Smart Images

Figure CN119055564A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a composition for calming skin, comprising wild ginseng root protoplasts and 2,3-butanediol. Background Art
[0002] Wild ginseng (Panax ginseng C. A Meyer), the ancestor of Korean ginseng, is a perennial shade-loving herb belonging to the Araliaceae family and the genus Panax. It has been used as medicine in Korea for a long time.
[0003] Recently, the technology of using cutting-edge bioengineering technology to culture plants in laboratory tissues has been developed, making it possible to use bioreactors (bioreactors) to stably produce tissues or cells of difficult-to-cultivate medicinal plants throughout the year without being affected by pests and diseases, seasonal changes, soil composition, etc., and with the development of these technologies, research aimed at applying plant cells to cosmetic compositions is also underway.
[0004] Protoplasts are protoplasts in which the cell walls of cells are removed and only the cell membrane remains. Research has been conducted on their use in fusing plant cells or introducing active substances that can be used as cosmetic ingredients (Korean Patent Publication No. 10-2016-0068190), but research on cosmetic compositions using plant protoplasts themselves as raw materials is lacking.
[0005] In particular, regarding wild ginseng, cosmetic compositions using extracts or single ingredients obtained therefrom have been studied, but research on cosmetic compositions using wild ginseng protoplasts is insufficient.
[0006] On the other hand, 2,3-butanediol is known to have moisturizing and antibacterial effects, but its effects on soothing the skin or alleviating skin irritation are still unknown.
[0007] Under such circumstances, the present inventors have confirmed that a composition containing wild ginseng root protoplasts and 2,3-butanediol has excellent skin soothing and skin irritation alleviating effects by reducing the expression of inflammatory factors caused by irritation, and have completed the present invention. Summary of the invention
[0008] Issues to be resolved
[0009] An object of the present invention is to provide a cosmetic composition for calming the skin comprising wild ginseng root protoplasts and 2,3-butanediol as effective ingredients.
[0010] Another object of the present invention is to provide a quasi-drug composition for calming the skin comprising wild ginseng root protoplasts and 2,3-butanediol as active ingredients.
[0011] Solution to the problem
[0012] It is specifically described as follows. On the other hand, each description and embodiment disclosed in the present invention can also be applied to each different description and embodiment. That is, all combinations of the various elements disclosed in the present invention belong to the scope of the present invention. In addition, it cannot be considered that the scope of the present invention is limited by the specific description described below.
[0013] One aspect of the present invention for achieving the above object provides a composition for calming skin comprising wild ginseng protoplasts and 2,3-butanediol as effective ingredients.
[0014] The term "protoplast" of the present invention may refer to a protoplast form in which callus is induced from the stem, leaf or root of ginseng and cultured, the cell wall is removed and only the cell membrane exists. More specifically, in the present invention, it may refer to ginseng root protoplast, but is not limited thereto.
[0015] Wild ginseng (Panaxginseng CA Meyer) is the ancestor of Korean ginseng. It is a perennial shade-loving herb belonging to the Araliaceae family and the genus Panax. It has been used as medicine in Korea for a long time. In particular, the discovery of natural wild ginseng is becoming increasingly rare, and it is known as a mysterious medicine discovered by a few ginseng collectors. Wild ginseng is divided into four types: heavenly ginseng, earthly ginseng, human ginseng, and long-brained ginseng. Heavenly ginseng, earthly ginseng, and human ginseng are wild ginsengs that are grown naturally in the mountains after birds eat their seeds. Long-brained wild ginseng refers to those whose wild ginseng seeds are artificially cultivated in the wild.
[0016] More specifically, the wild ginseng root protoplasts may be included in the composition of the present invention in a weight (w / w) % of 0.00001 to 10%, 0.0001 to 1%, 0.0001 to 0.1%, 0.0001 to 0.01%, 0.0001 to 0.001%.
[0017] In addition, the wild ginseng root protoplasts may be included in the composition of the present invention in a weight ratio of 1:10000 to 10:10000 relative to the total weight of the composition, but is not limited thereto.
[0018] The term "2,3-butanediol" of the present invention is an organic compound of the chemical formula (CH3CHOH)2, which exists in three stereoisomers, a chiral pair and a meso isomer, and is a colorless liquid.
[0019] More specifically, 2,3-butanediol may be included in the composition of the present invention in an amount of 0.0001 to 50%, 0.001 to 30%, 0.01 to 25%, or 0.1 to 20% by weight (w / w).
[0020] In addition, the 2,3-butanediol may be included in the composition of the present invention in a weight ratio of 1:1000 to 20:100 relative to the total weight of the composition, but is not limited thereto.
[0021] The term "skin calming" in the present invention refers to relieving and calming irritation reactions induced on the skin, namely abnormal skin reactions such as erythema, heat sensation, pain, rash, etc., and may include the concept of relieving skin inflammatory reactions and relieving skin irritation.
[0022] The stimulation induced on the skin may include all external stimulations, such as physical, chemical, electrical stimulation or ambient temperature changes that may cause abnormal skin reactions, and specifically, may be stimulation caused by UV or skin inflammation, but is not limited thereto.
[0023] In one embodiment of the present invention, by treating wild ginseng root protoplasts and 2,3-butanediol, the expression of inflammatory factors IL-6 and IL-8 caused by UV stimulation was confirmed to be reduced, which is different from the untreated group and the group treated with wild ginseng root protoplasts and 2,3-butanediol alone, in which the inhibitory effect of inflammatory factors could not be confirmed or was very small. It was confirmed that a significant inhibitory effect of inflammatory factors was exerted, the effect of calming the skin or relieving skin irritation could be confirmed, and the synergistic effect corresponding to the mixed treatment group compared with the single treatment group could be confirmed.
[0024] In addition, by confirming the inhibitory effect of NO (nitric oxide) production induced by LPS (lipopolysaccharide), the effect of calming the skin or relieving skin irritation against skin inflammatory irritation can be confirmed. In addition, it can be confirmed that this inflammatory factor inhibitory effect corresponds to the synergistic effect of the mixed treatment group compared with the single treatment group.
[0025] Another aspect of the present invention provides a cosmetic composition for calming the skin comprising wild ginseng root protoplasts and 2,3-butanediol as effective ingredients.
[0026] The above terms "ginseng root protoplasts" and "2,3-butanediol" are as described above.
[0027] In one embodiment of the present invention, the composition can be used to calm the skin against UV stimulation and skin inflammation, but is not limited thereto.
[0028] In one embodiment of the present invention, the composition can inhibit the expression of inflammatory factors caused by stimulation, more specifically IL-6, IL-8 or NO, but is not limited thereto.
[0029] In the present invention, the cosmetic composition can be prepared into a dosage form selected from the group consisting of solution, external ointment, cream, foam, nourishing lotion, softening lotion, facial mask, skin softener, emulsion, primer, essence, liquid cleanser, bath agent, sunscreen, sunscreen oil, suspension, emulsion, paste, gel, dew, powder, soap, cleaning agent containing surfactant, oil, powder foundation, emulsion foundation, wax foundation, patch and spray, but is not limited thereto.
[0030] In the present invention, the above-mentioned cosmetic composition may further contain one or more cosmetically acceptable carriers that are added to general skin cosmetics. As conventional ingredients, for example, oil, water, surfactants, moisturizers, lower alcohols, thickeners, chelating agents, pigments, preservatives, fragrances, etc. may be appropriately added, but are not limited to these.
[0031] The cosmetically acceptable carrier contained in the cosmetic composition of the present invention varies depending on the dosage form of the cosmetic composition.
[0032] When the dosage form of the present invention is an ointment, paste, cream or gel, as a carrier component, animal oil, vegetable oil, wax, paraffin, starch, tragacanth gum, cellulose derivatives, polyethylene glycol, silicone, bentonite, silicon dioxide, talc, zinc oxide, etc. can be used, but not limited thereto. These can be used alone or in combination of two or more.
[0033] When the dosage form of the present invention is a powder or a spray, lactose, talc, silicon dioxide, aluminum hydroxide, calcium silicate, polyamide powder, etc. can be used as a carrier component. In particular, when it is a spray, a propellant such as chlorofluorocarbon, propane / butane or dimethyl ether can be additionally contained, but it is not limited thereto. These can be used alone or in combination of two or more.
[0034] When the dosage form of the present invention is a solution or an emulsion, as a carrier component, a solvent, a solubilizing agent or an emulsifier can be used, and for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil, sesame oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan can be used, but it is not limited thereto. These can be used alone or in combination of two or more.
[0035] When the dosage form of the present invention is a suspension, as a carrier component, liquid diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitan esters and polyoxyethylene sorbitan esters, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth gum can be used, but are not limited thereto. These can be used alone or in combination of two or more.
[0036] When the dosage form of the present invention is soap, as a carrier component, alkali metal salts of fatty acids, fatty acid half ester salts, fatty acid protein hydrolysates (hydrolysates), isethionates (isethionates), lanolin derivatives, fatty alcohols, vegetable oils, glycerol, sugars, etc. can be used, but are not limited thereto. These can be used alone or in combination of two or more.
[0037] Another aspect of the present invention provides a quasi-drug composition for calming the skin comprising wild ginseng root protoplasts and 2,3-butanediol as effective ingredients.
[0038] The above terms "ginseng root protoplasts" and "2,3-butanediol" are as described above.
[0039] In addition to the above-mentioned ingredients, the pharmaceutical quasi-product composition of the present invention may also contain pharmaceutically acceptable carriers, excipients or diluents as required. The pharmaceutically acceptable carriers, excipients or diluents are not limited as long as they do not impair the effects of the present invention, and may include fillers, extenders, binders, wetting agents, disintegrants, surfactants, lubricants, sweeteners, aromatics, preservatives, etc.
[0040] The quasi-drug composition of the present invention may be exemplified by disinfectant cleansers, bath foams, ointments, wet wipes, coatings, etc., but is not limited thereto, and the formulation method, dosage, utilization method, constituent components, etc. of the quasi-drug may be appropriately selected from conventional techniques known in the technical field.
[0041] Another aspect of the present invention provides a method for calming skin or relieving skin irritation, comprising the step of administering a composition for calming skin comprising wild ginseng root protoplasts and 2,3-butanediol as effective ingredients to an individual.
[0042] The term "administration" used in the present invention refers to introducing the composition of the present invention into a patient by any appropriate method, and the administration route of the above composition can be any general route as long as it can reach the target tissue. Based on the characteristics of the composition of the present invention that is effective in calming the skin or relieving skin irritation, the administration route of the above composition can be administered by applying it on the skin.
[0043] The composition of the present invention can be administered daily or intermittently, and the number of administrations per day can be divided into 1 or 2-3 times for administration. In addition, in order to calm the skin or relieve skin irritation, the composition of the present invention can be used alone or in combination with other drug treatments. Considering all the above factors, it is important to be able to administer the amount that can achieve the maximum effect with the minimum amount without side effects, and it can be easily determined by those skilled in the art.
[0044] In the present invention, the term "subject" refers to all animals including humans, such as mice, rats, and livestock, that have or may have skin irritation. Specifically, it can be mammals including humans.
[0045] Another aspect of the present invention provides use of a composition comprising wild ginseng root protoplasts and 2,3-butanediol as effective ingredients for calming the skin.
[0046] The above terms, wild ginseng root protoplast, 2,3-butanediol, and skin calming are as described above.
[0047] Another aspect of the present invention provides use of a composition comprising wild ginseng root protoplasts and 2,3-butanediol as effective ingredients in preparing a cosmetic composition for calming the skin.
[0048] The above terms, wild ginseng root protoplast, 2,3-butanediol, and skin calming are as described above.
[0049] Effects of the Invention
[0050] In the case of the composition for calming the skin according to the present invention comprising wild ginseng root protoplasts and 2,3-butanediol as active ingredients, it was confirmed that it has excellent skin calming and skin irritation relief effects by reducing the expression of inflammatory factors caused by stimulation, and therefore can be effectively used in cosmetics, quasi-drugs, etc. for calming the skin or relieving skin irritation. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] Figure 1 This is a result confirming the skin soothing and skin irritation alleviating effects brought about by the composition of the present invention suppressing the expression of inflammatory factors.
[0052] Figure 2 This is a result confirming the skin soothing and skin irritation alleviating effects brought about by the composition of the present invention suppressing the expression of inflammatory factors.
[0053] Figure 3 This is a result confirming the skin soothing and skin irritation alleviating effects brought about by the composition of the present invention suppressing the expression of inflammatory factors.
[0054] Figure 4 This is a result confirming the skin soothing and skin irritation alleviating effects brought about by the composition of the present invention suppressing the expression of inflammatory factors.
[0055] Figure 5 This is a result confirming the skin soothing and skin irritation alleviating effects brought about by the composition of the present invention suppressing the expression of inflammatory factors. DETAILED DESCRIPTION
[0056] Hereinafter, the present invention will be described in detail by the following examples. However, the following examples are only for illustrating the present invention, and the scope of the present invention is not limited by the following examples.
[0057] Preparation Example 1. Preparation of wild ginseng root protoplasts
[0058] Callus was induced from the root of wild ginseng and cultured, and then the cell wall was removed to prepare a protoplast form in which only the cell membrane existed.
[0059] Specifically, excellent cell strains are selected from the roots of wild ginseng, and liquid suspension culture is performed, and then the cell walls of the suspension culture are removed by enzyme treatment, and protoplasts are collected by filtration and purification. Thereafter, the collected protoplasts are nano-granulated to prepare raw materials.
[0060] Example 1. Confirmation of the inhibition of cytokine inflammatory factor expression by wild ginseng root protoplasts and 2,3-butanediol
[0061] In order to confirm the sedative effect of wild ginseng root protoplasts and 2,3-butanediol (supplier: CosBridge, CAS number: 5341-95-7), HaCaT cells were used to evaluate the changes in the expression of inflammatory factors using wild ginseng root protoplasts and 2,3-butanediol at concentrations of 0.000488%, 0.001-0.1%, and their mixed samples (wild ginseng root protoplasts 0.000488% + 2,3-butanediol 0.001-0.1%).
[0062] The above samples were exposed to UV 30mJ / cm 2 The cells were treated together and cultured for 24 hours, then RNA was extracted to prepare cDNA, and the expression changes were evaluated by qRT-PCR using cytokine primers (IL-6, IL-8) (Tables 1 to 3 and Figures 1 to 4 ).
[0063] [Table 1]
[0064]
[0065] [Table 2]
[0066]
[0067] [Table 3]
[0068]
[0069] The results are shown in Tables 1 to 3 and Figures 1 to 4 It can be confirmed that the 2 Compared with the control group, ginseng root protoplasts alone (0.000488%), and 2,3-butanediol alone (0.1%, 0.01%, and 0.001%), the expression levels of IL-6 and IL-8 in the mixed sample of the two decreased by 33.63%, 38.61%, and 36.22%, respectively.
[0070] As a result, it was confirmed that the expression of inflammatory factors caused by UV stimulation was significantly reduced by the combination of wild ginseng root protoplasts and 2,3-butanediol, which resulted in a skin soothing effect and a skin irritation alleviating effect.
[0071] In addition, it was confirmed that this effect was a synergistic effect, which showed a significant effect when the mixed sample was treated with wild ginseng root protoplasts and 2,3-butanediol as compared with the single sample.
[0072] Furthermore, as shown in Tables 1 and 3, a heterogeneous effect of reducing the inflammatory factors IL-6 and IL-8 was not observed in the wild ginseng root protoplasts and 2,3-butanediol single samples, but was observed only in the mixed sample treatment.
[0073] Example 2. Confirmation of the inhibition of NO (Nitric Oxide) inflammatory factor expression by wild ginseng root protoplasts and 2,3-butanediol
[0074] In order to confirm the sedative effect of wild ginseng root protoplasts and 2,3-butanediol, the changes in the expression of inflammatory factors were evaluated using RAW 264.7 using wild ginseng root protoplasts (0.000488%) and 2,3-butanediol at concentrations of 0.001-0.1%, as well as their mixed samples (wild ginseng root protoplasts 0.000488% + 2,3-butanediol 0.001-0.1%).
[0075] Except for the untreated group, LPS 1ug / mL was treated to induce inflammation. The evaluation samples (negative control group: LPS only, positive control group: LPS + L-NMMA 20ug / mL) were diluted and treated according to the concentration, cultured for 24 hours, and then NO (Nitric Oxide) production assay was performed. The NO inhibition rate induced by LPS was confirmed (Table 4 and Figure 5 ).
[0076] [Table 4]
[0077]
[0078] The results are shown in Table 4 and Figure 5 It was confirmed that the NO generation amount was reduced by 79.6% in the mixed sample treatment compared with the control group treated with LPS alone and the wild ginseng root protoplasts and 2,3-butanediol alone.
[0079] As a result, it was confirmed that the expression of inflammatory factors caused by LPS stimulation was significantly reduced by the combination of wild ginseng root protoplasts and 2,3-butanediol, which resulted in skin soothing effect and skin irritation alleviating effect.
[0080] In addition, it was confirmed that this effect was a synergistic effect, which showed a significant effect when the mixed sample was treated with wild ginseng root protoplasts and 2,3-butanediol as compared with the single sample.
[0081] Based on the above description, those skilled in the art to which the present invention belongs can understand that the present invention can also be implemented in other specific ways without changing the technical idea or necessary features of the present invention. In this regard, it should be understood that the embodiments described above are exemplary and non-restrictive in all aspects. The scope of the present invention should be interpreted as including the meaning and scope of the patent claims described later and all changes or deformations derived from their equivalent concepts, rather than just the above detailed description.
Claims
1. A cosmetic composition for calming the skin, comprising wild ginseng root protoplasts and 2,3-butanediol as active ingredients.
2. The cosmetic composition according to claim 1, wherein The content of the wild ginseng root protoplasts is 0.00001 to 10% by weight (w / w).
3. The cosmetic composition according to claim 1, wherein The above-mentioned 2,3-butanediol is contained in 0.0001 to 50% by weight (w / w).
4. The cosmetic composition according to claim 1, wherein The above composition is used to calm the skin against UV irritation or skin inflammation.
5. The cosmetic composition according to claim 1, wherein The above composition inhibits the expression of inflammatory factors IL-6, IL-8 or NO.
6. A quasi-drug composition for calming the skin, comprising wild ginseng root protoplasts and 2,3-butanediol as active ingredients.
7. The quasi-drug composition according to claim 6, wherein The above composition is used to calm the skin against UV irritation or skin inflammation.
